<DOC>
	<DOCNO>NCT01753310</DOCNO>
	<brief_summary>The purpose protocol evaluate efficacy safety Dysport® use 2 mL dilution compare placebo treatment Cervical Dystonia .</brief_summary>
	<brief_title>Efficacy Safety DYSPORT® Using 2mL Dilution Adults With Cervical Dystonia .</brief_title>
	<detailed_description />
	<mesh_term>Dystonia</mesh_term>
	<mesh_term>Dystonic Disorders</mesh_term>
	<mesh_term>Torticollis</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<criteria>Primary diagnosis Cervical Dystonia least 9 month since onset either previously untreated botulinum toxin currently treat Botox total dosing range 100200 U ≤60 U sternocleidomastoid muscle last injection cycle , satisfactory treatment response principal investigator 's judgment last two sequential Botox treatment cycle . TWSTRS total score≥ 20 ; TWSTRSseverity subscale score &gt; 10 ; In apparent remission Cervical Dystonia Diagnosis pure retrocollis pure anterocollis For nonnaïve subject , previous poor response either last two Botox treatment Known requirement &lt; 100U &gt; 200U Botox inject neck muscle</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>